| Literature DB >> 24549147 |
Deirdre J Murphy1, Clare Dunney2, Aoife Mullally3, Nita Adnan4, Tom Fahey5, Joe Barry6.
Abstract
Most studies of alcohol consumption in pregnancy have looked at one time point only, often relying on recall. The aim of this longitudinal study was to determine whether alcohol consumption changes in early and late pregnancy and whether this affects perinatal outcomes. We performed a prospective cohort study, conducted from November 2010 to December 2011 at a teaching hospital in the Republic of Ireland. Of the 907 women with a singleton pregnancy who booked for antenatal care and delivered at the hospital, 185 (20%) abstained from alcohol in the first trimester but drank in the third trimester, 105 (12%) consumed alcohol in the first and third trimesters, and the remaining 617 (68%) consumed no alcohol in pregnancy. Factors associated with continuing to drink in pregnancy included older maternal age (30-39 years), Irish nationality, private healthcare, smoking, and a history of illicit drug use. Compared to pre-pregnancy, alcohol consumption in pregnancy was markedly reduced, with the majority of drinkers consuming ≤ 5 units per week (92% in first trimester, 72-75% in third trimester). Perhaps because of this, perinatal outcomes were similar for non-drinkers, women who abstained from alcohol in the first trimester, and women who drank in the first and third trimester of pregnancy. Most women moderate their alcohol consumption in pregnancy, especially in the first trimester, and have perinatal outcomes similar to those who abstain.Entities:
Mesh:
Year: 2014 PMID: 24549147 PMCID: PMC3945584 DOI: 10.3390/ijerph110202049
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Cohort Flow Chart.
Characteristics of Study Cohort in relation to the hospital population.
| Characteristic | Study Population at Recruitment i | Study Population at Third Trimester ii | Study Population at Delivery iii | General Hospital Population iv |
|---|---|---|---|---|
| Maternal age at booking | ||||
| <20 years | 34 (2.6) | 19 (2.1) | 31 (2.5) | 200 (3.0) |
| 20–24 years | 161 (12.4) | 102 (11.2) | 152 (12.5) | 776 (11.6) |
| 25–29 years | 362 (27.8) | 235 (25.9) | 336 (27.6) | 1,527 (22.7) |
| 30–34 years | 453 (34.8) | 334 (36.8) | 427 (35.1) | 2,322 (34.6) |
| 35–39 years | 247 (19.0) | 188 (20.7) | 232 (19.1) | 1,592 (23.7) |
| >40 years | 43 (3.3) | 29 (3.2) | 38 (3.1) | 301 (4.5) |
| Marital status | ||||
| Married | 679 (52.2) | 505 (55.7) | 635 (52.2) | 3,952 (58.5) |
| Single | 621 (47.8) | 402 (44.3) | 581 (47.8) | 2,685 (40.0) |
| Socioeconomic group | ||||
| Professional | 341 (26.2) | 258 (28.4) | 317 (26.1) | 2,077 (30.9) |
| Home duties | 222 (17.1) | 135 (14.9) | 206 (16.9) | 961 (14.3) |
| Non-manual | 491 (37.8) | 369 (40.7) | 481 (39.6) | 2,622 (39.0) |
| Manual | 65 (5.0) | 44 (4.9) | 46 (3.8) | 267 (4.0) |
| Unemployed | 117 (9.0) | 50 (5.5) | 103 (8.5) | 501 (7.5) |
| Non-classifiable | 64 (4.9) | 51 (5.6) | 63 (5.2) | 289 (4.3) |
| Nationality | ||||
| Irish | 888 (68.3) | 618 (68.1) | 839 (69.0) | 5,510 (82.0) |
| Non-Irish | 412 (31.7) | 289 (31.9) | 377 (31.0) | 1,189 (17.7) |
| Gestation at booking
| ||||
| <12 weeks | 528 (40.8) | 369 (40.7) | 493 (40.5) | 2,666 (39.8) |
| 12–20 weeks | 729 (56.3) | 523 (57.7) | 687 (56.5) | 3,683 (55.0) |
| >20 weeks | 37 (2.9) | 15 (1.7) | 36 (3.0) | 349 (5.2) |
| Private Health Care | ||||
| Yes | 145 (11.2) | 122 (13.5) | 142 (11.7) | 1,219 (18.1) |
| No | 1,155 (88.8) | 785 (86.5) | 1,074 (88.3) | 5,499 (81.9) |
i Recruitment took place at participants first antenatal visit to the hospital (usually 10–14 weeks’); ii The third trimester questionnaire was completed by participants from 28 weeks’ gestation; iii Study population at delivery includes intrauterine death n = 7 and neonatal death n = 1; iv General hospital population—Murphy et al. (2013) [13]; * Missing data for gestational age at booking n = 6.
Alcohol-related knowledge and behaviours according to alcohol exposure in pregnancy.
| Total | Ex-Drinker All Pregnancy | Third Trimester Drinker Only | First and Third Trimester Drinker |
|---|---|---|---|
| Aware of units of alcohol in drinks(moderate or good knowledge) | 46 (10.4) | 21 (11.3) | 20 (19.1) |
| Aware of recommended alcohol units women should not exceed | 35 (7.9) | 16 (8.6) | 16 (15.2) |
| Units consumed pre-pregnancy | 279 (63.3) | 73 (39.5) | 44 (41.9) |
| Alcohol source ii | 30 (6.8) | 7 (3.7) | 6 (5.8) |
| Units consumed first trimester | __ | __ | 97 (92.4) |
| Units consumed third trimester | __ | 135 (73.0) | 79 (75.2) |
i Excludes never drinkers, n = 176; ii Some women consume more than one type of alcoholic drink; * Chi-square test for difference in proportions ∫ p < 0.01.
Characteristics of women according to alcohol exposure in pregnancy.
| Total | Non-Drinker | Third trimester only | First and Third Trimester | Odds ratio i 95% Confidence Intervals | Odds ratio ii 95% Confidence Intervals |
|---|---|---|---|---|---|
| Maternal age | 16 (2.6) | 2 (1.1) | 1 (1.0)26 (24.7)74 (70.5)4 (3.8) | 0.58 (0.13–2.60) | 0.62 (0.08–4.83) |
| Single Marital status | 260 (42.1) | 90 (48.6) | 52 (49.5) | 1.30 (0.94–1.81) | 1.35 (0.89–2.04) |
| Socioeconomic group | 159 (25.8) | 64 (34.6) | 35 (33.3) | 1.73 (1.01–2.97) | 1.68 (0.85–3.32)1.00 |
| Irish Nationality | 383 (62.1) | 148 (80.0) | 87 (82.9) | 2.44 (1.65–3.63)
| 2.95 (1.73–5.03)
|
| Private Health Care | 68 (11.0) | 33 (17.8) | 21 (20.0) | 1.75 (1.11–2.76)
| 2.02 (1.18–3.47)
|
| Nulliparous | 290 (47.0) | 91 (49.2) | 38 (36.2) | 1.09 (0.79–1.52) | 0.64 (0.42–0.98) |
| Unplanned pregnancy | 202 (32.7) | 52 (28.1) | 34 (32.4) | 0.80 (0.56–1.15) | 0.98 (0.63–1.53) |
| Gestation at booking | 255 (41.3) | 78 (42.2) | 36 (34.3) | 1.00 | 1.00 |
| Current smoker | 56 (9.1) | 25 (13.5) | 29 (27.6) | 1.57 (0.95–2.59) | 3.82 (2.30–6.36)
|
| Illicit drug use (ever) | 57 (9.2) | 34 (18.4) | 24 (22.9) | 2.21 (1.39–3.51)
| 2.91 (1.71–4.95)
|
| Social worker referral | 16 (2.6) | 5 (2.7) | 1 (1.0) | 1.04 (0.38–2.75) | 0.36 (0.05–2.75) |
i Third trimester only vs. Non-drinker; ii First and Third trimester vs. Non-drinker; ∫ Reference category; * p < 0.05; Missing data for gestational age n = 6.
Perinatal outcomes according to alcohol exposure in first and third trimester of pregnancy and third trimester only.
| Alcohol Intake | Non-Drinker | Third Trimester Only Alcohol | First and Third Trimester Alcohol | Third Trimester Only | First and Third Trimester |
|---|---|---|---|---|---|
| Gestational age (weeks) Mean (SD) Range Mean difference (95% CI) | 39.6 (1.5) | 40.0 (1.5) | 39.7 (1.5) | 0.4 (0.2–0.6) | 0.1 (−0.2–0.4) |
| Birth weight (g) Mean (SD) Range Mean difference (95% CI) | 3,460 (498) | 3,494 (500) | 3,527 (571) | 34 (−48–116) | 67 (−39–173) |
| Preterm birth <37 weeks (%) | 33 (5.3) | 6 (3.2) | 3 (2.9) | 0.77 (0.50–1.20) | 0.52 (0.16–1.73) |
| Low birth weight <2,500 g (%) | 23 (3.7) | 5 (2.7) | 3 (2.9) | 0.72 (0.27–1.91) | 0.76 (0.22–2.58) |
| Intrauterine growth restriction i, ii (%) | 80 (13.0) | 32 (17.3) | 13 (12.4) | 1.40 (0.90–2.20) | 0.95 (0.51–1.77) |
| Apgar score <7 at 5 min (%) | 5 (0.9) | 1 (0.5) | 1 (1.0) | 0.67 (0.08–5.73) | 1.18 (0.14–10.2) |
| Admitted to neonatal unit (%) | 108 (17.5) | 29 (15.7) | 11 (10.5) | 0.88 (0.56–1.37) | 0.55 (0.29–1.07) |
i Adjusted for maternal age, socio-economic group, Irish nationality, private healthcare, current smoker, history of illicit drug use; ii Customised birth weight <10th percentile; * p < 0.05.
| Item | Item No | Recommendation |
|---|---|---|
| Title and abstract | 1 | ( |
| ( | ||
| Background/Rationale | 2 | Explain the scientific background and rationale for the investigation being reported |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses |
| Study design | 4 | Present key elements of study design early in the paper |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection |
| Participants | 6 | ( |
| ( | ||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable |
| Data sources/Measurement | 8 * | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group |
| Bias | 9 | Describe any efforts to address potential sources of bias |
| Study size | 10 | Explain how the study size was arrived at |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why |
| Statistical methods | 12 | (a) Describe all statistical methods, including those used to control for confounding |
| (b) Describe any methods used to examine subgroups and interactions | ||
| (c) Explain how missing data were addressed | ||
| (d) If applicable, explain how loss to follow-up was addressed | ||
| (e) Describe any sensitivity analyses | ||
| Participants | 13
| (a) Report numbers of individuals at each stage of study—e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed |
| (b) Give reasons for non-participation at each stage | ||
| (c) Consider use of a flow diagram | ||
| Descriptive data | 14
| (a) Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders |
| (b) Indicate number of participants with missing data for each variable of interest | ||
| (c) Summarise follow-up time (e.g., average and total amount) | ||
| Outcome data | 15
| Report numbers of outcome events or summary measures over time |
| Main results | 16 | (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval). Make clear which confounders were adjusted for and why they were included |
| (b) Report category boundaries when continuous variables were categorized | ||
| (c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period | ||
| Other analyses | 17 | Report other analyses done—e.g., analyses of subgroups and interactions, and sensitivity analyses |
| Key results | 18 | Summarise key results with reference to study objectives |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results |
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based |
* Give information separately for exposed and unexposed groups. Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com). Information on the STROBE Initiative is available at http://www.strobe-statement.org.